Wellable acquires MeYou Health's Daily Challenge product, Omada's mental health program free for six months and more digital health news briefs

Also: FDA clears Nuvo Group's fetal and maternal heart monitor for pregnant women; Innovaccer, Sanitas USA launch virtual COVID-19 care app.
By Dave Muoio
04:09 pm
Share

From me to you. Employee-wellness company Wellable has acquired assets from fellow digital-wellness product-maker MeYou Health, the companies announced. While the terms of the deal were not disclosed, it does transfer ownership of MeYou's Daily Challenge product to Wellable. This program encourages healthy eating, physical activity, stress management and other behaviors through daily email and text-message suggestions, and encourages individuals to engage their social network as they do so.

“We are so excited about the opportunity to provide our clients with the clinically validated Daily Challenge solution,” Nick Patel, CEO of Wellable, said in a statement. “This product has been validated in the academic and organizational arenas, and we are looking forward to expanding its footprint and impact.”


Mental health resources during trying times. Omada Health announced today that U.S. employers and health plans will be able to provide the chronic-disease-management startup's Behavioral Health Program to their members at no cost. The digital program matches members with a dedicated live coach and other resources to help reduce their stress, anxiety or depression.

"Millions across the country are currently experiencing increased levels of stress, anxiety, and depression in response to COVID-19, and the demand and need for mental health support far exceed the available supply. Social distancing requirements make the digital delivery of this care ever-more important," the company wrote in its announcement.  "We are in an era that calls on every person and organization to do what they can for those around us, and offering Omada for Behavioral Health at no cost for the next six months is one step that Omada can take to answer that call.


FDA clears remote monitor for pregnant moms. Tel Aviv, Israel-based Nuvo Group has received a 510(k) clearance for INVU, a remote-monitoring platform that measures fetal and maternal heart rates during pregnancy. The product takes the form of a sensor band that connects with a smartphone app that provides personalized insights to the mother and detailed heart-rate data to her provider. The company says its device will only be available with a prescription, and it's intended for mothers at least 32 weeks into a singleton pregnancy.

“Nuvo was founded to provide 21st century technology and tools that enable distributed pregnancy care. Meeting 510(k) requirements has been an important part of the mission to ensure that we are delivering safe and effective prenatal monitoring solutions remotely,” Oren Oz, founder and CEO of Nuvo Group, said in a statement. “Now more than ever, distance health solutions like INVU are needed to minimize pregnant women’s exposure to crowded offices and infectious hospitals settings.”


Innovaccer, Sanitas launch virtual COVID-19 care. Sanitas USA, a healthcare provider active in Florida, New Jersey, Texas and Connecticut, has tapped health-data startup Innovaccer to support a virtual COVID-19 screening and triage program, the companies announced today. The app-based resource will facilitate virtual calls and remote-monitoring features, help providers compile clinical notes and auto-fill forms necessary for state health department case-reporting requirements.

"This platform has the functionality to assist providers in protecting the public, patients at high-risk, as well as themselves and their families against this relentless virus," Abhinav Shashank, CEO and cofounder of Innovaccer, said in a statement. "We have designed this technology to help organizations optimize their existing medical resources in order to stay on top of a dynamic situation while working to minimize the devastating effect of a worldwide pandemic.”

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!